Clinical Significance of Altered Expression of β-Catenin and E-Cadherin in Oral Dysplasia and Cancer: Potential Link with ALCAM Expression

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Kaur, Jatinder ^a   Sawhney, Meenakshi ^b   DattaGupta, Siddhartha ^b   Shukla, Nootan Kumar ^c   Srivastava, Anurag ^b   Walfish, Paul G ^a,d,e   Ralhan, Ranju ^a,d,e  

^a MOUNT SINAI HOSPITAL   (Canada)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c INSTITUTE ROTARY CANCER HOSPITAL   (India)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BETA CATENIN; UVOMORULIN;

ADULT; AGED; ARTICLE; BIOACCUMULATION; CANCER CELL; CANCER RADIOTHERAPY; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; CYTOPLASM; DYSPLASIA; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOUTH CANCER; MOUTH DISEASE; MOUTH DYSPLASIA; MOUTH SQUAMOUS CELL CARCINOMA; ORAL SURGERY; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, CD; BETA CATENIN; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES, NEURONAL; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; FETAL PROTEINS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; PRECANCEROUS CONDITIONS; RNA, SMALL INTERFERING;

EID: 84879522355     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067361     Document Type: Article

References (55)

1. Giehl K, Menke A, (2008) Microenvironmental regulation of E-cadherin-mediated adherens junctions. Front Biosci 13: 3975-3985.
2. Niessen CM, Gottardi CJ, (2008) Molecular components of the adherens junction. Biochim Biophys Acta 1778: 562-571.
3. Wells A, Chao YL, Grahovac J, Wu Q, Lauffenburger DA, (2011) Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis. Front Biosci 16: 815-837.
4. Baum B, Georgiou M, (2011) Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling. J Cell Biol 192: 907-917.
5. Hajra KM, Fearon ER, (2002) Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 34: 255-268.
6. Lunter PC, van Kilsdonk JW, van Beek H, Cornelissen IM, Bergers M, et al. (2005) Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity. Cancer Res 65: 8801-8808.
7. Brembeck FH, Rosario M, Birchmeier W, (2006) Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 16: 51-59.
8. Campo-Trapero J, Cano-Sanchez J, Palacios-Sanchez B, Sanchez-Gutierrez JJ, Gonzalez-Moles MA, et al. (2008) Update on molecular pathology in oral cancer and precancer. Anticancer Res 28: 1197-1205.
9. Franceschi S, Bidoli E, Herrero R, Munoz N, (2000) Comparison of cancers of the oral cavity and pharynx worldwide, etiological clues. Oral Oncol 36: 106-115.
10. Warnakulasuriya S, Johnson NW, van der Waal I, (2007) Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36: 575-580.
11. Hunter KD, Parkinson EK, Harrison PR, (2005) Profiling early head and neck cancer. Nat Rev Cancer 5: 127-135.
12. Gupta PC, Mehta FS, Daftary DK, Pindborg JJ, Bhonsle RB, et al. (1980) Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol 8: 283-333.
13. Arora S, Matta A, Shukla NK, Deo SV, Ralhan R, (2005) Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog 42: 97-108.
14. Rohatgi N, Matta A, Kaur J, Srivastava A, Ralhan R, (2006) Novel molecular targets of smokeless tobacco (khaini) in cell culture from oral hyperplasia. Toxicology 224: 1-13.
15. Ofori-Acquah SF, King JA, (2008) Activated leukocyte cell adhesion molecule: a new paradox in cancer. Transl Res 151: 122-128.
16. Wai Wong C, Dye DE, Coombe DR, (2012) The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis. Int J Cell Biol 2012: 340296.
17. Sawhney M, Matta A, Macha MA, Kaur J, DattaGupta S, et al. (2009) Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients. Int J Cancer 124: 2098-2105.
18. Lim SC, Zhang S, Ishii G, Endoh Y, Kodama K, et al. (2004) Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res 10: 166-172.
19. Matta A, DeSouza LV, Shukla NK, Gupta SD, Ralhan R, et al. (2008) Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res 7: 2078-2087.
20. Kaur J, Ralhan R, (2003) Establishment and characterization of a cell line from smokeless tobacco associated oral squamous cell carcinoma. Oral Oncol 39: 806-820.
21. Sawhney M, Rohatgi N, Kaur J, Shishodia S, Sethi G, et al. (2007) Expression of NF-kappaB parallels COX-2 expression in oral precancer and cancer, association with smokeless tobacco. Int J Cancer 120: 2545-2556.
22. Alt-Holland A, Zhang W, Margulis A, Garlick JA, (2005) Microenvironmental control of premalignant disease: the role of intercellular adhesion in the progression of squamous cell carcinoma. Semin Cancer Biol 15: 84-96.
23. Iwai S, Yonekawa A, Harada C, Hamada M, Katagiri W, et al. (2010) Involvement of the Wnt-beta-catenin pathway in invasion and migration of oral squamous carcinoma cells. Int J Oncol 37: 1095-1103.
24. Odajima T, Sasaki Y, Tanaka N, Kato-Mori Y, Asanuma H, et al. (2005) Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features. Hum Pathol 36: 234-241.
25. Zhang W, Alt-Holland A, Margulis A, Shamis Y, Fusenig NE, et al. (2006) E-cadherin loss promotes the initiation of squamous cell carcinoma invasion through modulation of integrin-mediated adhesion. J Cell Sci 119: 283-291.
26. Kudo Y, Kitajima S, Ogawa I, Hiraoka M, Sargolzaei S, et al. (2004) Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clin Cancer Res 10: 5455-5463.
27. Chien MH, Chou LS, Chung TT, Lin CH, Chou MY, et al. (2012) Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathologic development of oral cancer. Head Neck 34: 405-11.
28. Maeda G, Chiba T, Aoba T, Imai K, (2007) Epigenetic inactivation of E-cadherin by promoter hypermethylation in oral carcinoma cells. Odontology 95: 24-29.
29. Yang J, Weinberg RA, (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829.
30. Ishida K, Ito S, Wada N, Deguchi H, Hata T, et al. (2007) Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia. Mol Cancer 6: 62.
31. Wang L, Liu T, Wang Y, Cao L, Nishioka M, et al. (2007) Altered expression of desmocollin 3, desmoglein 3, and beta-catenin in oral squamous cell carcinoma: correlation with lymph node metastasis and cell proliferation. Virchows Arch 451: 959-966.
32. Tanaka Y, Nakanishi H, Kakunaga S, Okabe N, Kawakatsu T, et al. (2003) Role of nectin in formation of E-cadherin-based adherens junctions in keratinocytes: analysis with the N-cadherin dominant negative mutant. Mol Biol Cell 14: 1597-1609.
33. Bankfalvi A, Krassort M, Vegh A, Felszeghy E, Piffko J, (2002) Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J Oral Pathol Med 31: 450-457.
34. Bankfalvi A, Piffko J, (2000) Prognostic and predictive factors in oral cancer: the role of the invasive tumour front. J Oral Pathol Med 29: 291-298.
35. Shieh YS, Chang LC, Chiu KC, Wu CW, Lee HS, (2003) Cadherin and catenin expression in mucoepidermoid carcinoma: correlation with histopathologic grade, clinical stage, and patient outcome. J Oral Pathol Med 32: 297-304.
36. de Aguiar A Jr, Kowalski LP, de Almeida OP, (2007) Clinicopathological and immunohistochemical evaluation of oral squamous cell carcinoma in patients with early local recurrence. Oral Oncol 43: 593-601.
37. Lyons AJ, Jones J, (2007) Cell adhesion molecules, the extracellular matrix and oral squamous carcinoma. Int J Oral Maxillofac Surg 36: 671-679.
38. Ueda G, Sunakawa H, Nakamori K, Shinya T, Tsuhako W, et al. (2006) Aberrant expression of beta- and gamma-catenin is an independent prognostic marker in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 35: 356-361.
39. Stenner M, Yosef B, Huebbers CU, Preuss SF, Dienes HP, et al. (2011) Nuclear translocation of beta-catenin and decreased expression of epithelial cadherin in human papillomavirus-positive tonsillar cancer, an early event in human papillomavirus-related tumour progression? Histopathology 58: 1117-1126.
40. Ihnen M, Kress K, Kersten JF, Kilic E, Choschzick M, et al. (2012) Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients. BMC cancer 12: 140.
41. Tachezy M, Zander H, Gebauer F, Marx A, Kaifi JT, et al. (2012) Activated leukocyte cell adhesion molecule (CD166)-Its prognostic power for colorectal cancer patients. J Surg Res 177: e15-20.
42. Piao D, Jiang T, Liu G, Wang B, Xu J, et al. (2012) Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer. Mol Biol Rep 39: 661-668.
43. van Kilsdonk JW, Takahashi N, Weidle U, Burtscher H, Jarry J, et al. (2012) Modulation of Activated Leukocyte Cell Adhesion Molecule-Mediated Invasion Triggers an Innate Immune Gene Response in Melanoma. J Invest Dermatol 132: 1462-1470.
44. De Craene B, Berx G, (2013) Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13: 97-110.
45. Kalluri R, Weinberg RA, (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
46. Nieto MA, Cano A, (2012) The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. Semin Cancer Biol 22: 361-368.
47. Scanlon CS, Van Tubergen EA, Inglehart RC, D'Silva NJ, (2013) Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. Dent Res 92: 114-121.
48. Nijkamp MM, Span PN, Hoogsteen IJ, van der Kogel AJ, Kaanders JH, et al. (2011) Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients. Radiother Oncol 99: 344-348.
49. Mandal M, Myers JN, Lippman SM, Johnson FM, Williams MD, et al. (2008) Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 112: 2088-2100.
50. Liu LK, Jiang XY, Zhou XX, Wang DM, Song XL, et al. (2010) Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome. Mod Pathol 23: 213-224.
51. Vidya Priyadarsini R, Senthil Murugan R, Nagini S, (2011) Aberrant activation of Wnt/beta-catenin signaling pathway contributes to the sequential progression of DMBA-induced HBP carcinomas. Oral Oncol 48: 33-39.
52. Iwai S, Yonekawa A, Harada C, Hamada M, Katagiri W, et al. (2010) Involvement of the Wnt-beta-catenin pathway in invasion and migration of oral squamous carcinoma cells. Int J Oncol 37: 1095-1103.
53. Uraguchi M, Morikawa M, Shirakawa M, Sanada K, Imai K, (2004) Activation of WNT family expression and signaling in squamous cell carcinomas of the oral cavity. J Dent Res 83: 327-332.
54. Muzio L Lo, (2001) A possible role for the WNT-1 pathway in oral carcinogenesis. Crit Rev Oral Biol Med 12: 152-165.
55. Zhao D, Tang XF, Yang K, Liu JY, Ma XR, (2012) Over-expression of integrin-linked kinase correlates with aberrant expression of Snail, E-cadherin and N-cadherin in oral squamous cell carcinoma: implications in tumor progression and metastasis. Clin Exp Metastasis 29: 957-969.